Sep 21, 2026 12 0
Uploaded by Genevieve
Favorite
Share
More Options
8
A real-world disproportionality analysis of the US Food and Drug Administration (FDA) adverse event reporting system (FAERS) events for Durvalumab_Page 1

Open in WPS to view all 8 pages